Mayo Clinic strategic transactions and intellectual property have been instrumental to the creation and success of numerous collaborations, exclusive agreements, start-up companies, business ventures and equity investments.
Below is a small sampling.
Impact stories
Cancer screening revolution
FDA-approved noninvasive colorectal screening
Read case study
Remote ECG patient monitoring
Mayo Clinic IP paves way for FDA-cleared remote heart monitoring device
Read case study
Magnetic Resonance Elastography
Revolutionary imaging tool for diagnosing liver fibrosis
Read case study
Innovation Spotlight
Created to enhance the expression of target antigens, a novel single-cycle adenovirus vaccine platform developed by Mayo Clinic will be used to target multiple infectious diseases and cancer indications, beginning with a Phase I clinical study investigating a vaccine for COVID-19.
Content displayed is subject to change.